MovDisordV3, PascalFrancis, Corpus, bibRecord, 001022

The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil

Identifieur interne : 001022 ( PascalFrancis/Corpus ); précédent : 001021; suivant : 001023

The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil

Auteurs : Laura Silveira-Moriyama ; Margarete De Jesus Carvalho ; Regina Katzenschlager ; Aviva Petrie ; Ronald Ranvaud ; Egberto Reis Barbosa ; Andrew J. Lees

Source :

Movement disorders [ 0885-3185 ] ; 2008.

RBID : Pascal:09-0058919

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Pathologie du système nerveux, Essai identification, Diagnostic, Brésil, Olfaction.

English descriptors

KwdEn :
- Brazil, Diagnosis, Identification test, Nervous system diseases, Olfaction, Parkinson disease.

Abstract

Smell identification tests may be of routine clinical value in the differential diagnosis of PD but are subject to cultural variation and have not been systematically evaluated in the Brazilian population. We have applied culturally adapted translations of the University of Pennsylvania 40-item smell identification test (UPSIT-40) and the 16-item identification test from Sniffin' Sticks (SS-16) to nondemented Brazilian PD patients and controls. Pearson's correlation coefficient between the test scores was 0.76 (95% CI 0.70-0.81, n = 204, P < 0.001). To calculate reliability measures for each test we used the diagnosis (either PD or control) as outcome variable for separate logistic regression analyses using the score in the UPSIT-40 or the SS-16 as a covariate. The SS-16 specificity was 89.0% with a sensitivity of 81.1% (106 PD and 118 controls), The UPSIT-40 specificity was 83.5% and its sensitivity 82.1% (95 PD and 109 controls). Regression curves were used to associate an individual's smell test score with the probability of belonging to the PD, as opposed to the control group. Our data provide support for the use of the UPSIT-40 and SS-16 to help distinguish early PD from controls.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 23`
A06				`@2 16`
A08	`01`	`1`	`ENG`	`@1 The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil`
A11	`01`	`1`		`@1 SILVEIRA-MORIYAMA (Laura)`
A11	`02`	`1`		`@1 CARVALHO (Margarete De Jesus)`
A11	`03`	`1`		`@1 KATZENSCHLAGER (Regina)`
A11	`04`	`1`		`@1 PETRIE (Aviva)`
A11	`05`	`1`		`@1 RANVAUD (Ronald)`
A11	`06`	`1`		`@1 REIS BARBOSA (Egberto)`
A11	`07`	`1`		`@1 LEES (Andrew J.)`
A14	`01`			`@1 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology @2 London @3 GBR @Z 1 aut. @Z 7 aut.`
A14	`02`			`@1 Neurology Department, São Paulo School of Medicine, University of São Paulo @2 São Paulo @3 BRA @Z 2 aut. @Z 6 aut.`
A14	`03`			`@1 Department of Neurology, DonauspitallSozialmedizinisches Zentrum Ost @2 Vienna @3 AUT @Z 3 aut.`
A14	`04`			`@1 Biostatistics Unit, UCL Eastman Dental Institute @2 London @3 GBR @Z 4 aut.`
A14	`05`			`@1 Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sdo Paulo @2 São Paulo @3 BRA @Z 5 aut.`
A20				`@1 2328-2334`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000196116650060`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 40 ref.`
A47	`01`	`1`		`@0 09-0058919`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Smell identification tests may be of routine clinical value in the differential diagnosis of PD but are subject to cultural variation and have not been systematically evaluated in the Brazilian population. We have applied culturally adapted translations of the University of Pennsylvania 40-item smell identification test (UPSIT-40) and the 16-item identification test from Sniffin' Sticks (SS-16) to nondemented Brazilian PD patients and controls. Pearson's correlation coefficient between the test scores was 0.76 (95% CI 0.70-0.81, n = 204, P < 0.001). To calculate reliability measures for each test we used the diagnosis (either PD or control) as outcome variable for separate logistic regression analyses using the score in the UPSIT-40 or the SS-16 as a covariate. The SS-16 specificity was 89.0% with a sensitivity of 81.1% (106 PD and 118 controls), The UPSIT-40 specificity was 83.5% and its sensitivity 82.1% (95 PD and 109 controls). Regression curves were used to associate an individual's smell test score with the probability of belonging to the PD, as opposed to the control group. Our data provide support for the use of the UPSIT-40 and SS-16 to help distinguish early PD from controls.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 02`
C03	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 02`
C03	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 02`
C03	`03`	`X`	`FRE`	`@0 Essai identification @5 09`
C03	`03`	`X`	`ENG`	`@0 Identification test @5 09`
C03	`03`	`X`	`SPA`	`@0 Prueba identificación @5 09`
C03	`04`	`X`	`FRE`	`@0 Diagnostic @5 10`
C03	`04`	`X`	`ENG`	`@0 Diagnosis @5 10`
C03	`04`	`X`	`SPA`	`@0 Diagnóstico @5 10`
C03	`05`	`X`	`FRE`	`@0 Brésil @2 NG @5 11`
C03	`05`	`X`	`ENG`	`@0 Brazil @2 NG @5 11`
C03	`05`	`X`	`SPA`	`@0 Brasil @2 NG @5 11`
C03	`06`	`X`	`FRE`	`@0 Olfaction @5 12`
C03	`06`	`X`	`ENG`	`@0 Olfaction @5 12`
C03	`06`	`X`	`SPA`	`@0 Olfación @5 12`
C07	`01`	`X`	`FRE`	`@0 Amérique du Sud @2 NG`
C07	`01`	`X`	`ENG`	`@0 South America @2 NG`
C07	`01`	`X`	`SPA`	`@0 America del sur @2 NG`
C07	`02`	`X`	`FRE`	`@0 Amérique @2 NG`
C07	`02`	`X`	`ENG`	`@0 America @2 NG`
C07	`02`	`X`	`SPA`	`@0 America @2 NG`
C07	`03`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`04`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`06`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`06`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`06`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 040`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 09-0058919 INIST
ET :	The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil
AU :	SILVEIRA-MORIYAMA (Laura); CARVALHO (Margarete De Jesus); KATZENSCHLAGER (Regina); PETRIE (Aviva); RANVAUD (Ronald); REIS BARBOSA (Egberto); LEES (Andrew J.)
AF :	Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology/London/Royaume-Uni (1 aut., 7 aut.); Neurology Department, São Paulo School of Medicine, University of São Paulo/São Paulo/Brésil (2 aut., 6 aut.); Department of Neurology, DonauspitallSozialmedizinisches Zentrum Ost/Vienna/Autriche (3 aut.); Biostatistics Unit, UCL Eastman Dental Institute/London/Royaume-Uni (4 aut.); Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sdo Paulo/São Paulo/Brésil (5 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2008; Vol. 23; No. 16; Pp. 2328-2334; Bibl. 40 ref.
LA :	Anglais
EA :	Smell identification tests may be of routine clinical value in the differential diagnosis of PD but are subject to cultural variation and have not been systematically evaluated in the Brazilian population. We have applied culturally adapted translations of the University of Pennsylvania 40-item smell identification test (UPSIT-40) and the 16-item identification test from Sniffin' Sticks (SS-16) to nondemented Brazilian PD patients and controls. Pearson's correlation coefficient between the test scores was 0.76 (95% CI 0.70-0.81, n = 204, P < 0.001). To calculate reliability measures for each test we used the diagnosis (either PD or control) as outcome variable for separate logistic regression analyses using the score in the UPSIT-40 or the SS-16 as a covariate. The SS-16 specificity was 89.0% with a sensitivity of 81.1% (106 PD and 118 controls), The UPSIT-40 specificity was 83.5% and its sensitivity 82.1% (95 PD and 109 controls). Regression curves were used to associate an individual's smell test score with the probability of belonging to the PD, as opposed to the control group. Our data provide support for the use of the UPSIT-40 and SS-16 to help distinguish early PD from controls.
CC :	002B17; 002B17G
FD :	Maladie de Parkinson; Pathologie du système nerveux; Essai identification; Diagnostic; Brésil; Olfaction
FG :	Amérique du Sud; Amérique; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central
ED :	Parkinson disease; Nervous system diseases; Identification test; Diagnosis; Brazil; Olfaction
EG :	South America; America; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD :	Parkinson enfermedad; Sistema nervioso patología; Prueba identificación; Diagnóstico; Brasil; Olfación
LO :	INIST-20953.354000196116650060
ID :	09-0058919

Links to Exploration step

Pascal:09-0058919

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil</title>
<author><name sortKey="Silveira Moriyama, Laura" sort="Silveira Moriyama, Laura" uniqKey="Silveira Moriyama L" first="Laura" last="Silveira-Moriyama">Laura Silveira-Moriyama</name>
<affiliation><inist:fA14 i1="01"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Carvalho, Margarete De Jesus" sort="Carvalho, Margarete De Jesus" uniqKey="Carvalho M" first="Margarete De Jesus" last="Carvalho">Margarete De Jesus Carvalho</name>
<affiliation><inist:fA14 i1="02"><s1>Neurology Department, São Paulo School of Medicine, University of São Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Katzenschlager, Regina" sort="Katzenschlager, Regina" uniqKey="Katzenschlager R" first="Regina" last="Katzenschlager">Regina Katzenschlager</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, DonauspitallSozialmedizinisches Zentrum Ost</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Petrie, Aviva" sort="Petrie, Aviva" uniqKey="Petrie A" first="Aviva" last="Petrie">Aviva Petrie</name>
<affiliation><inist:fA14 i1="04"><s1>Biostatistics Unit, UCL Eastman Dental Institute</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ranvaud, Ronald" sort="Ranvaud, Ronald" uniqKey="Ranvaud R" first="Ronald" last="Ranvaud">Ronald Ranvaud</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sdo Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Reis Barbosa, Egberto" sort="Reis Barbosa, Egberto" uniqKey="Reis Barbosa E" first="Egberto" last="Reis Barbosa">Egberto Reis Barbosa</name>
<affiliation><inist:fA14 i1="02"><s1>Neurology Department, São Paulo School of Medicine, University of São Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation><inist:fA14 i1="01"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0058919</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 09-0058919 INIST</idno>
<idno type="RBID">Pascal:09-0058919</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001022</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil</title>
<author><name sortKey="Silveira Moriyama, Laura" sort="Silveira Moriyama, Laura" uniqKey="Silveira Moriyama L" first="Laura" last="Silveira-Moriyama">Laura Silveira-Moriyama</name>
<affiliation><inist:fA14 i1="01"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Carvalho, Margarete De Jesus" sort="Carvalho, Margarete De Jesus" uniqKey="Carvalho M" first="Margarete De Jesus" last="Carvalho">Margarete De Jesus Carvalho</name>
<affiliation><inist:fA14 i1="02"><s1>Neurology Department, São Paulo School of Medicine, University of São Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Katzenschlager, Regina" sort="Katzenschlager, Regina" uniqKey="Katzenschlager R" first="Regina" last="Katzenschlager">Regina Katzenschlager</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, DonauspitallSozialmedizinisches Zentrum Ost</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Petrie, Aviva" sort="Petrie, Aviva" uniqKey="Petrie A" first="Aviva" last="Petrie">Aviva Petrie</name>
<affiliation><inist:fA14 i1="04"><s1>Biostatistics Unit, UCL Eastman Dental Institute</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ranvaud, Ronald" sort="Ranvaud, Ronald" uniqKey="Ranvaud R" first="Ronald" last="Ranvaud">Ronald Ranvaud</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sdo Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Reis Barbosa, Egberto" sort="Reis Barbosa, Egberto" uniqKey="Reis Barbosa E" first="Egberto" last="Reis Barbosa">Egberto Reis Barbosa</name>
<affiliation><inist:fA14 i1="02"><s1>Neurology Department, São Paulo School of Medicine, University of São Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation><inist:fA14 i1="01"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brazil</term>
<term>Diagnosis</term>
<term>Identification test</term>
<term>Nervous system diseases</term>
<term>Olfaction</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Essai identification</term>
<term>Diagnostic</term>
<term>Brésil</term>
<term>Olfaction</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Smell identification tests may be of routine clinical value in the differential diagnosis of PD but are subject to cultural variation and have not been systematically evaluated in the Brazilian population. We have applied culturally adapted translations of the University of Pennsylvania 40-item smell identification test (UPSIT-40) and the 16-item identification test from Sniffin' Sticks (SS-16) to nondemented Brazilian PD patients and controls. Pearson's correlation coefficient between the test scores was 0.76 (95% CI 0.70-0.81, n = 204, P < 0.001). To calculate reliability measures for each test we used the diagnosis (either PD or control) as outcome variable for separate logistic regression analyses using the score in the UPSIT-40 or the SS-16 as a covariate. The SS-16 specificity was 89.0% with a sensitivity of 81.1% (106 PD and 118 controls), The UPSIT-40 specificity was 83.5% and its sensitivity 82.1% (95 PD and 109 controls). Regression curves were used to associate an individual's smell test score with the probability of belonging to the PD, as opposed to the control group. Our data provide support for the use of the UPSIT-40 and SS-16 to help distinguish early PD from controls.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>16</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SILVEIRA-MORIYAMA (Laura)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CARVALHO (Margarete De Jesus)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>KATZENSCHLAGER (Regina)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PETRIE (Aviva)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>RANVAUD (Ronald)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>REIS BARBOSA (Egberto)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>LEES (Andrew J.)</s1>
</fA11>
<fA14 i1="01"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Neurology Department, São Paulo School of Medicine, University of São Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, DonauspitallSozialmedizinisches Zentrum Ost</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Biostatistics Unit, UCL Eastman Dental Institute</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sdo Paulo</s1>
<s2>São Paulo</s2>
<s3>BRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>2328-2334</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000196116650060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>40 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0058919</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Smell identification tests may be of routine clinical value in the differential diagnosis of PD but are subject to cultural variation and have not been systematically evaluated in the Brazilian population. We have applied culturally adapted translations of the University of Pennsylvania 40-item smell identification test (UPSIT-40) and the 16-item identification test from Sniffin' Sticks (SS-16) to nondemented Brazilian PD patients and controls. Pearson's correlation coefficient between the test scores was 0.76 (95% CI 0.70-0.81, n = 204, P < 0.001). To calculate reliability measures for each test we used the diagnosis (either PD or control) as outcome variable for separate logistic regression analyses using the score in the UPSIT-40 or the SS-16 as a covariate. The SS-16 specificity was 89.0% with a sensitivity of 81.1% (106 PD and 118 controls), The UPSIT-40 specificity was 83.5% and its sensitivity 82.1% (95 PD and 109 controls). Regression curves were used to associate an individual's smell test score with the probability of belonging to the PD, as opposed to the control group. Our data provide support for the use of the UPSIT-40 and SS-16 to help distinguish early PD from controls.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Essai identification</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Identification test</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Prueba identificación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Brésil</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Brazil</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Brasil</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Olfaction</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Olfaction</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Olfación</s0>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Amérique du Sud</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>South America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>America del sur</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Amérique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>040</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 09-0058919 INIST</NO>
<ET>The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil</ET>
<AU>SILVEIRA-MORIYAMA (Laura); CARVALHO (Margarete De Jesus); KATZENSCHLAGER (Regina); PETRIE (Aviva); RANVAUD (Ronald); REIS BARBOSA (Egberto); LEES (Andrew J.)</AU>
<AF>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology/London/Royaume-Uni (1 aut., 7 aut.); Neurology Department, São Paulo School of Medicine, University of São Paulo/São Paulo/Brésil (2 aut., 6 aut.); Department of Neurology, DonauspitallSozialmedizinisches Zentrum Ost/Vienna/Autriche (3 aut.); Biostatistics Unit, UCL Eastman Dental Institute/London/Royaume-Uni (4 aut.); Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sdo Paulo/São Paulo/Brésil (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2008; Vol. 23; No. 16; Pp. 2328-2334; Bibl. 40 ref.</SO>
<LA>Anglais</LA>
<EA>Smell identification tests may be of routine clinical value in the differential diagnosis of PD but are subject to cultural variation and have not been systematically evaluated in the Brazilian population. We have applied culturally adapted translations of the University of Pennsylvania 40-item smell identification test (UPSIT-40) and the 16-item identification test from Sniffin' Sticks (SS-16) to nondemented Brazilian PD patients and controls. Pearson's correlation coefficient between the test scores was 0.76 (95% CI 0.70-0.81, n = 204, P < 0.001). To calculate reliability measures for each test we used the diagnosis (either PD or control) as outcome variable for separate logistic regression analyses using the score in the UPSIT-40 or the SS-16 as a covariate. The SS-16 specificity was 89.0% with a sensitivity of 81.1% (106 PD and 118 controls), The UPSIT-40 specificity was 83.5% and its sensitivity 82.1% (95 PD and 109 controls). Regression curves were used to associate an individual's smell test score with the probability of belonging to the PD, as opposed to the control group. Our data provide support for the use of the UPSIT-40 and SS-16 to help distinguish early PD from controls.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Pathologie du   système nerveux; Essai identification; Diagnostic; Brésil; Olfaction</FD>
<FG>Amérique du Sud; Amérique; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du   système nerveux central</FG>
<ED>Parkinson disease; Nervous system diseases; Identification test; Diagnosis; Brazil; Olfaction</ED>
<EG>South America; America; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Parkinson enfermedad; Sistema nervioso patología; Prueba identificación; Diagnóstico; Brasil; Olfación</SD>
<LO>INIST-20953.354000196116650060</LO>
<ID>09-0058919</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001022 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001022 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0058919
   |texte=   The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil

The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri